Figure 2.

Percentage of patients with a STRRS score ≥ 3 at different time points after a single dose administration of benzydamine HCl spray or benzydamine HCl lozenges as secondary endpoint of BePaiR study. A significant difference in the percentage of responders between the treatment with benzydamine HCl spray and benzydamine HCl lozenges was detected at 5, 30, and 60 min post dosing. A: PP population; B: m-ITT population. HCl = hydrochloride, m-ITT = modified intent-to-treat, STRRS = sore throat relief rating scale.